Frost & Sullivan analysis calls 2020 ‘an unforgiving but transformational year’ for healthcare

source

Frost & Sullivan’s recent analysis, Post-Pandemic Global Healthcare Market Outlook, 2020 has been launched as part of its global Transformational Health Growth Partnership Service program.

The analysis forecasts that 2020 will be an ‘unforgiving but transformational year,’ and shows that post COVID-19, the healthcare industry is expected to witness a drop in growth from 5.3% to 0.6% in 2020, with revenues remaining below the $2 trillion mark.

WHY IT MATTERS

In light of the lessons learned from the pandemic and the changing economic scenario, Frost & Sullivan has re-visited predictions, identified top growth opportunities, and analysed risk-mitigation measures adopted by companies to survive the remainder of 2020, including:

![image.png]()
ON THE RECORD

Lal adds: "While the life sciences segment seems to be surviving and thriving, in certain scenarios, medical technologies and imaging are expected to be hit the hardest. Elective procedures being on hold and delayed or prolonged procurement of capital equipment will have a negative impact on revenue, from $413.9 billion to $377.1 billion for medical devices and from $31.5 billion to $18.1 billion for imaging equipment.”

![1423769305268-1024x764.jpg]()

Please Follow me
@srcaptain

Connect On,,

Twitter

Facebook

Telegram


Thanks for visiting my post🥰